30266679|t|Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration.
30266679|a|Perturbations in iron homeostasis and iron accumulation feature in several neurodegenerative disorders including Alzheimer's disease (AD), Parkinson's disease (PD) and Amyotrophic lateral sclerosis (ALS). Proteins such as alpha-synuclein, tau and amyloid precursor protein that are pathologically associated with neurodegeneration are involved in molecular crosstalk with iron homeostatic proteins. Quantitative susceptibility mapping, an MRI based non-invasive technique, offers proximal evaluations of iron load in regions of the brain and powerfully predicts cognitive decline. Further, small molecules that target elevated iron have shown promise against PD and AD in preclinical studies and clinical trials. Despite these strong links between altered iron homeostasis and neurodegeneration the molecular biology to describe the association between enhanced iron levels and neuron death, synaptic impairment and cognitive decline is ill defined. In this review we discuss the current understanding of brain iron homeostasis and how it may be perturbed under pathological conditions. Further, we explore the ramifications of a novel cell death pathway called ferroptosis that has provided a fresh impetus to the "metal hypothesis" of neurodegeneration. While lipid peroxidation plays a central role in the execution of this cell death modality the removal of iron through chelation or genetic modifications appears to extinguish the ferroptotic pathway. Conversely, tissues that harbour elevated iron may be predisposed to ferroptotic damage. These emerging findings are of relevance to neurodegeneration where ferroptotic signalling may offer new targets to mitigate cell death and dysfunction.
30266679	19	23	iron	Chemical	MESH:D007501
30266679	32	36	Iron	Chemical	MESH:D007501
30266679	67	84	neurodegeneration	Disease	MESH:D019636
30266679	103	107	iron	Chemical	MESH:D007501
30266679	124	128	iron	Chemical	MESH:D007501
30266679	161	188	neurodegenerative disorders	Disease	MESH:D019636
30266679	199	218	Alzheimer's disease	Disease	MESH:D000544
30266679	220	222	AD	Disease	MESH:D000544
30266679	225	244	Parkinson's disease	Disease	MESH:D010300
30266679	246	248	PD	Disease	MESH:D010300
30266679	254	283	Amyotrophic lateral sclerosis	Disease	MESH:D000690
30266679	285	288	ALS	Disease	MESH:D000690
30266679	308	323	alpha-synuclein	Gene	6622
30266679	325	328	tau	Gene	4137
30266679	333	358	amyloid precursor protein	Gene	351
30266679	399	416	neurodegeneration	Disease	MESH:D019636
30266679	458	462	iron	Chemical	MESH:D007501
30266679	590	594	iron	Chemical	MESH:D007501
30266679	648	665	cognitive decline	Disease	MESH:D003072
30266679	713	717	iron	Chemical	MESH:D007501
30266679	745	747	PD	Disease	MESH:D010300
30266679	752	754	AD	Disease	MESH:D000544
30266679	842	846	iron	Chemical	MESH:D007501
30266679	863	880	neurodegeneration	Disease	MESH:D019636
30266679	948	952	iron	Chemical	MESH:D007501
30266679	964	976	neuron death	Disease	MESH:D009410
30266679	978	997	synaptic impairment	Disease	MESH:D012183
30266679	1002	1019	cognitive decline	Disease	MESH:D003072
30266679	1097	1101	iron	Chemical	MESH:D007501
30266679	1323	1340	neurodegeneration	Disease	MESH:D019636
30266679	1348	1353	lipid	Chemical	MESH:D008055
30266679	1448	1452	iron	Chemical	MESH:D007501
30266679	1585	1589	iron	Chemical	MESH:D007501
30266679	1676	1693	neurodegeneration	Disease	MESH:D019636
30266679	Association	MESH:D019636	4137
30266679	Positive_Correlation	MESH:D007501	MESH:D010300
30266679	Association	MESH:D007501	MESH:D019636
30266679	Positive_Correlation	MESH:D007501	MESH:D000690
30266679	Positive_Correlation	MESH:D007501	MESH:D000544
30266679	Positive_Correlation	MESH:D007501	MESH:D003072
30266679	Association	MESH:D019636	351
30266679	Positive_Correlation	MESH:D007501	MESH:D012183
30266679	Positive_Correlation	MESH:D007501	MESH:D009410
30266679	Association	MESH:D007501	351
30266679	Association	MESH:D007501	6622
30266679	Association	MESH:D007501	4137
30266679	Association	MESH:D019636	6622

